JCR Pharmaceuticals Co., Ltd. (TYO:4552)
Japan · Delayed Price · Currency is JPY 497.00
+2.00 (0.40%)
May 29, 2026, 3:30 PM JST
JCR Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, JCR Pharmaceuticals stock has a consensus rating of "Hold" and an average price target of ¥717. The average 1-year stock price forecast is 44.20% higher than the current stock price, while the lowest is ¥550 (+10.66%) and the highest is ¥900 (+81.09%).
Price Target: ¥717 (+44.20%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for JCR Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 6 | 6 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Citi No rating | Citi | Hold Maintains ¥540 | Hold | Maintains | ¥540 | +8.65% | May 25, 2026 |
| Jefferies | Jefferies | Buy Upgrades ¥900 | Buy | Upgrades | ¥900 | +81.09% | Apr 16, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.